Details of the Drug
General Information of Drug (ID: DM17GMN)
| Drug Name |
EG-011
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Ad-VEGF D; Trinam-variants (refractory angina), Ark Therpeutics Group; Adenoviral short-form VEGF D gene therapy (angina/peripheral vascular disease), Ark Therapeutics; Short form VEGF-D gene therapy (refractory angina/peripheral vascular disease), Ark Therapeutics Group
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References

